| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000245522.2 |
Vismodegib |
Bladder urothelial carcinoma |
0.025794507 |
Resistant |
| ENSG00000245522.2 |
Vismodegib |
Skin cutaneous melanoma |
0.01710248 |
Resistant |
| ENSG00000245522.2 |
Vismodegib |
Sarcoma |
0.03418817 |
Sensitive |
| ENSG00000245522.2 |
Vismodegib |
Stomach adenocarcinoma |
0.026564218 |
Sensitive |
